(INNS)
ZINLIRVIMAB(INNC)
IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120 ENVELOPE GLYCOPROTEIN N-GLYCAN V3 REGION], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-461) [VH (HOMO SAPIENS IGHV4-4*08 (79.2%) -(IGHD) - IGHJ6*04 (85.0%), CDR-IMGT [8.7.26] (26-33.51- 57.96-121)) (1-132) -HOMO SAPIENS IGHG1*01, G1M17,1, G1V24 CH3 L107, S114 (CH1 K120 (229) (133-230), HINGE 1-15 (231-245), CH2 (246-355), CH3 D12 (371), L14 (373), M107>L (443), N114>S (449) (356-460), CHS K2>DEL (461)) (133-461)], (235-213')- DISULFIDE WITHLAMBDA2 LIGHT CHAIN HOMO SAPIENS (1'- 214') [V-LAMBDA (HOMO SAPIENS IGLV3-21*01 (64.9%) -IGLJ2*01 (80.0%) G121>A (102), K123>R (104), CDR-IMGT [6.3.12] (22-27.45-47.87-98)) (1'- 108') -HOMO SAPIENS IGLC2*01 (100%) (109'-214')]; DIMER (241-241'':244-244'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHOK1SV, GLYCOFORM ALFA(WHO)
ZINLIRVIMABUM(INN)